Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
A recent study published in the Annals of Epidemiology found that diabetes and postmenopausal surgery are associated with kidney stone disease (KSD).
Read Full NewsThree medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.
Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.
Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.
1.
Early palliative care billing up from 2010 to 2019 for advanced cancer
2.
Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.
3.
FDA Approves Hemophilia B Second Gene Therapy.
4.
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group
5.
The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.
1.
Obesity is a major risk factor for cancer
2.
AI in Genomics: Decoding the Human Genome for Cancer Treatment
3.
The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence
4.
Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection
5.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge